Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Therefore, monitoring alterations in PG expression within intestinal L cells is essential for understanding GLP-1 secretion
Key index paths: Neuropathy, neuropathic main term subterm peripheral subterm by etiology (alcoholic, diabetic, drug-induced, hereditary, idiopathic, inflammatory, ischemic, toxic) Neuropathy, peripheral, diabetic see E08E13 with .40.49 Polyneuropathy main term subterms by etiology (alcoholic G62.1, critical illness G62.81, diabetic [see Diabetes, with neuropathy], drug-induced G62.0, hereditary G60.x, idiopathic G60.9, inflammatory G61.x, radiation G62.82, toxic G62.2) Syndrome, carpal tunnel G56.0- Syndrome, tarsal tunnel G57.5- Syndrome, Guillain-Barr G61.0 Neuropathy, CIDP G61.81 Disease, Charcot-Marie-Tooth G60.0 Meralgia paresthetica G57.1- Neuralgia, post-herpetic B02.29 (other PHN) or B02.22 (trigeminal) Degeneration, subacute combined G32.0 Dysautonomia G90.1 (familial), G90.09 (other idiopathic) Syndrome, Refsum G60.1 Coder Note When the index leads to see also Diabetes, with, neuropathy always confirm documentation of the specific type of diabetes (Type 1, Type 2, secondary, drug-induced) before selecting the E-code subcategory
in Spain, its current prevalence ranges between 2833%11,12 and it is a recognized as a cardiovascular risk factor and increases the mortality in this population.1315 Furthermore, in patients with DM2 and advanced CKD there are limitations in the prescription of certain antihyperglycemic drugs (e.g., metformin or sulfonylureas) and there is an increased risk of hypoglycemia with antihyperglycemic treatment,16 a complication that is associated with increased cardiovascular risk17 and hinders the achievement of glycemic control targets
11 ChoiE.DuanC.BaiX
Although the impact of GLP-1RAs on CD outcomes is not well defined, some preclinical data suggest that GLP-1RAs have anti-inflammatory and gut barrier-protective effects
